Efrat L Amitay
Overview
Explore the profile of Efrat L Amitay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
439
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lau D, Shaw E, McMullen S, Cowling T, Witges K, Amitay E, et al.
BMC Nephrol
. 2024 Jul;
25(1):244.
PMID: 39080608
Background: Chronic kidney disease (CKD) poses a substantial burden to individuals, caregivers, and healthcare systems. CKD is associated with higher risk for adverse events, including renal failure, cardiovascular disease, and...
2.
Health Care Costs Associated with the Development and Combination of Cardio-Renal-Metabolic Diseases
Nichols G, Amitay E, Chatterjee S, Steubl D
Kidney360
. 2023 Jul;
4(10):1382-1388.
PMID: 37461134
No abstract available.
3.
Nichols G, Amitay E, Chatterjee S, Steubl D
Metab Syndr Relat Disord
. 2023 May;
21(5):261-266.
PMID: 37130317
The cardiometabolic syndrome focuses on the association between type 2 diabetes mellitus (T2DM) and atherosclerotic cardiovascular disease (ASCVD), whereas the cardiorenal syndrome focuses on the association between chronic kidney disease...
4.
Ugai T, Haruki K, Harrison T, Cao Y, Qu C, Chan A, et al.
Am J Gastroenterol
. 2023 Jan;
118(4):712-726.
PMID: 36707929
Introduction: Early-onset colorectal cancer diagnosed before the age of 50 years has been increasing. Likely reflecting the pathogenic role of the intestinal microbiome, which gradually changes across the entire colorectal...
5.
Ugai T, Akimoto N, Haruki K, Harrison T, Cao Y, Qu C, et al.
J Gastroenterol
. 2023 Jan;
58(3):229-245.
PMID: 36648535
Background: The pathogenic effect of colorectal tumor molecular features may be influenced by several factors, including those related to microbiota, inflammation, metabolism, and epigenetics, which may change along colorectal segments....
6.
Alwers E, Kather J, Kloor M, Brobeil A, Tagscherer K, Roth W, et al.
J Pathol Clin Res
. 2022 Nov;
9(2):129-136.
PMID: 36424650
In addition to the traditional staging system in colorectal cancer (CRC), the Immunoscore® has been proposed to characterize the level of immune infiltration in tumor tissue and as a potential...
7.
Georgeson P, Harrison T, Pope B, Zaidi S, Qu C, Steinfelder R, et al.
Nat Commun
. 2022 Jun;
13(1):3254.
PMID: 35668106
Carriers of germline biallelic pathogenic variants in the MUTYH gene have a high risk of colorectal cancer. We test 5649 colorectal cancers to evaluate the discriminatory potential of a tumor...
8.
Amitay E, Niedermaier T, Alwers E, Chang-Claude J, Hoffmeister M, Brenner H
JNCI Cancer Spectr
. 2022 Jun;
6(4).
PMID: 35642982
Background: Hormone-replacement therapy (HRT) is associated with lower colorectal cancer (CRC) risk among postmenopausal women. However, little is known about the effects of lifetime exposure of women to varying levels...
9.
Harlid S, van Guelpen B, Qu C, Gylling B, Aglago E, Amitay E, et al.
Int J Cancer
. 2022 Apr;
151(3):348-360.
PMID: 35383926
Diabetes is an established risk factor for colorectal cancer. However, colorectal cancer is a heterogeneous disease and it is not well understood whether diabetes is more strongly associated with some...
10.
Niedermaier T, Heisser T, Gies A, Guo F, Amitay E, Hoffmeister M, et al.
Int J Cancer
. 2021 Jul;
149(11):1877-1886.
PMID: 34278571
Colorectal cancer (CRC) incidence and prevalence of its precursors are substantially higher among males than among females in most countries but the reasons for the male excess risk are incompletely...